Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

US Patent 12338230 · Granted Jun 24, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compounds for the treatment of complement mediated disorders2025
Pharmaceutical compounds for the treatment of complement mediated disorders2025
Bax inhibitors and uses thereof2025
Multi-metal material build device using laser 3D printing, and working method th2025
Mop2025
Aldoketo reductase inhibitors and uses thereof2025
Systems and methods for selecting edge nodes for task performance2025
Systems and methods for resource-optimized mixed reality using user-centric adap2025
Method and apparatus for determining delay compensation value, device, and stora2025
Systems and methods for communication-aware federated learning2025
Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors2025
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2025